Pleiotropic functional properties of androgen receptor mutants in prostate cancer. (Q37272639)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800375%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

review article

1 reference

title

Pleiotropic functional properties of androgen receptor mutants in prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800375%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800375%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Jean-Pierre Bergerat

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800375%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

1 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800375%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800375%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800375%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

145-157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800375%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800375%20AND%20SRC:MED&resulttype=core&format=json

Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

The androgen receptor (AR) in syndromes of androgen insensitivity and in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen-dependent regulation of Her-2/neu in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Role of conserved hydrophobic amino acids in androgen receptor AF-1 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Transient, ligand-dependent arrest of the androgen receptor in subnuclear foci alters phosphorylation and coactivator interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Crystal Structure of the T877A Human Androgen Receptor Ligand-binding Domain Complexed to Cyproterone Acetate Provides Insight for Ligand-induced Conformational Changes and Structure-based Drug Design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Molecular analysis of the androgen-receptor gene in a family with receptor-positive partial androgen insensitivity: an unusual type of intronic mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Structural and functional consequences of glutamine tract variation in the androgen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Suppression of androgen receptor signaling in prostate cancer cells by an inhibitory receptor variant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

A yeast-based functional assay for the detection of the mutant androgen receptor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Constitutive activation of the androgen receptor by a point mutation in the hinge region: a new mechanism for androgen-independent growth in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen receptor mutants detected in recurrent prostate cancer exhibit diverse functional characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen receptor coregulators and their involvement in the development and progression of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Phosphoinositide 3-kinase-independent non-genomic signals transit from the androgen receptor to Akt1 in membrane raft microdomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen receptors in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen receptor cross-talk with cell signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Expression and function of androgen receptor coactivators in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Interleukin-6 regulation of prostate cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Agonist-antagonist induced coactivator and corepressor interplay on the human androgen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Mutation of histidine 874 in the androgen receptor ligand-binding domain leads to promiscuous ligand activation and altered p160 coactivator interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Targeting the androgen receptor in hormone-refractory prostate cancer--new concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: Androgen-receptor cofactors and bypass pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

The development of androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen Receptor Gene Amplification and Protein Expression in Recurrent Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Membrane rafts as potential sites of nongenomic hormonal signaling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Antisense targets to enhance hormone and cytotoxic therapies in advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

The androgen receptor gene mutations database (ARDB): 2004 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Principles for modulation of the nuclear receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Possible role of adaptive mutation in resistance to antiandrogen in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen receptor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

A splicing variant of the androgen receptor detected in a metastatic prostate cancer exhibits exclusively cytoplasmic actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

A novel androgen receptor mutant, A748T, exhibits hormone concentration-dependent defects in nuclear accumulation and activity despite normal hormone-binding affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Domains of the Human Androgen Receptor Involved in Steroid Binding, Transcriptional Activation, and Subcellular Localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Identification of two transcription activation units in the N-terminal domain of the human androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Current status of the molecular genetics of human prostatic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Regulatory mechanisms of osteoblast and osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

A glucocorticoid-responsive mutant androgen receptor exhibits unique ligand specificity: therapeutic implications for androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Unexpected paracrine action of prostate cancer cells harboring a new class of androgen receptor mutation--a new paradigm for cooperation among prostate tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Osteoblasts in prostate cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Structural basis for the glucocorticoid response in a mutant human androgen receptor (AR(ccr)) derived from an androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Molecular mechanisms of androgen receptor-mediated gene regulation: structure-function analysis of the AF-1 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

The adrenal androgen androstenediol is present in prostate cancer tissue after androgen deprivation therapy and activates mutated androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Unfaithfulness and promiscuity of a mutant androgen receptor in a hormone-refractory prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen receptor gene mutations in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

The role of the polyglutamine tract in androgen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Co-activator and co-repressor interplay on the human androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen receptor decoy molecules block the growth of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Uncoupling of hormone-dependence from chaperone-dependence in the L701H mutation of the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

The development and function of the skeleton and bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Coregulator codes of transcriptional regulation by nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Functional characterizations of the androgen receptor confirm that the molecular basis of androgen action is transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen receptor mutations are associated with Gleason score in localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Formation of the androgen receptor transcription complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

The androgen receptor: unlocking the secrets of its unique transactivation domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

5alpha-reductase activity in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen receptor gene mutations in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen receptor mutations in high-grade prostate cancer before hormonal therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Wnt3a growth factor induces androgen receptor-mediated transcription and enhances cell growth in human prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Roles and regulation of Wnt signaling and beta-catenin in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Selective DNA recognition by the androgen receptor as a mechanism for hormone-specific regulation of gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

The androgen receptor DNA-binding domain determines androgen selectivity of transcriptional response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen receptor corepressors: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

7 January 2021

Intranuclear organization and function of the androgen receptor

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

7 January 2021

Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

7 January 2021

Interplay between two hormone-independent activation domains in the androgen receptor

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

7 January 2021

Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

7 January 2021

Androgen receptor alterations in prostate cancer relapsed during a combined androgen blockade by orchiectomy and bicalutamide

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

7 January 2021

Pattern of somatic androgen receptor gene mutations in patients with hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

7 January 2021

Five novel androgen receptor gene mutations associated with complete androgen insensitivity syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

7 January 2021

Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

7 January 2021

Molecular analysis of the androgen receptor in ten prostate cancer specimens obtained before and after androgen ablation

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

7 January 2021

Specific properties of a C-terminal truncated androgen receptor detected in hormone refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

7 January 2021

Androgen Receptor Mutations Identified in Prostate Cancer and Androgen Insensitivity Syndrome Display Aberrant ART-27 Coactivator Function

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

7 January 2021

Natural disordered sequences in the amino terminal domain of nuclear receptors: lessons from the androgen and glucocorticoid receptors

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

7 January 2021

A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1)

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

7 January 2021

Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

7 January 2021

Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.20848

7 January 2021

Identifiers

DOI

10.1002/HUMU.20848

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800375%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference